CA
CLVS

Cortland Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Cortland Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-826,919
Closed -$72.7M – 49
2015
Q2 		$72.7M Buy
+826,919
New +$70.8M 1.18% 30

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Cortland Advisers's CLVS Position: Q3 2015 in Review

Cortland Advisers sold out of Clovis Oncology, Inc. (CLVS) in Q3 2015, closing a stake of 826,919 shares — an estimated $72.7M sold.

Cortland Advisers first reported a position in CLVS in Q2 2015 and held it in 1 quarter. The position peaked at $72.7M in Q2 2015. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

  • Cortland Advisers reported no remaining Clovis Oncology, Inc. position as of Q3 2015 after selling out during the quarter.
  • Cortland Advisers sold 826,919 Clovis Oncology, Inc. shares in Q3 2015, an estimated $72.7M.
  • Cortland Advisers first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 1 quarter.
  • Cortland Advisers's Clovis Oncology, Inc. position peaked at $72.7M in Q2 2015.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on Cortland Advisers's 13F filing for Q3 2015, filed 12 Nov 2015.